Sonire Therapeutics

Tokyo, Japan · Founded 2020 · Privately Held (backing)

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. Sonire Therapeutics is based in Tokyo, Japan and was founded in 2020. Its last reported valuation was $31.7 million in Nov 2022. It has raised $39.9 million across 1 recorded round; the latest was a $13.5 million early-stage round in Mar 2026.

Last reported valuation
$31.7M
Oct 2026
Priced at
—
Total raised
$39.9M
Last round
Early Stage VC
Mar 2026
What is Sonire Therapeutics worth?
$31.7Mlast reported valuation · Oct 2026

Sonire Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.

Free account
More of Sonire Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Sonire Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Sonire Therapeutics funding history

1 rounds
DateRoundRaisedPost-money
Mar 2026Early Stage VC$13.5M▮
Unlock post-money valuations

Membership and data by Private Market View

Sonire Therapeutics valuation

Sonire Therapeutics's last reported valuation was $31.7 million in Nov 2022. No priced round, secondary trade or fund mark has surfaced since.

How much has Sonire Therapeutics raised?

Sonire Therapeutics has raised $39.9 million in total; 1 of its rounds is on record. The largest on record was a $13.5 million early-stage round in Mar 2026.

Sonire Therapeutics has filed 1 Form D with the SEC, most recently in Apr 2026 ($13.5 million sold to 1 investor).

How Sonire Therapeutics's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Sonire Therapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →

Frequently asked about Sonire Therapeutics

What is Sonire Therapeutics worth?
Sonire Therapeutics is valued at $31.7M as of Oct 2026. Sonire Therapeutics's last reported valuation, Nov 2022. Nothing priced has surfaced since.
How much has Sonire Therapeutics raised?
Sonire Therapeutics has raised $39.9M in total funding across 1 recorded rounds.
When did Sonire Therapeutics last raise?
Sonire Therapeutics last raised in Mar 2026 (Early Stage VC), raising $13.5M.